Milk Polar Lipids for Abdominal Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether consuming milk polar lipids, a type of fat found in dairy, can reduce risks related to heart and metabolic health. Participants will take either a dairy powder rich in these lipids or a standard dairy powder for eight weeks. It is ideal for individuals with high LDL cholesterol and larger waistlines. As an Early Phase 1 trial, the research aims to understand how these lipids function in people, offering participants a chance to explore this potential health benefit.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications. The trial excludes people taking lipid-lowering medications, anti-inflammatory medications, and medications that affect blood clotting.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that milk polar lipids (MPLs) are generally safe for consumption. In one study, a formula containing milk fat globule membrane (a component of MPLs) was safe and well-tolerated by infants, with side effects similar to those normally expected in this age group.
Another study involving healthy adults found that high doses of milk fat globule membrane did not cause major safety issues, as participants reported no significant side effects.
These findings suggest that MPLs can be safely consumed. However, it is important to note that this trial is in an early stage, and the treatment is still being tested for safety.12345Why do researchers think this study treatment might be promising?
Unlike traditional treatments for abdominal obesity, which often involve medications or invasive procedures, the milk polar lipid (MPL)-rich dairy powder offers a more natural approach. This treatment is unique because it harnesses the power of milk polar lipids, believed to impact fat metabolism and potentially aid in reducing abdominal fat. Researchers are excited about this treatment's potential to provide a dietary alternative that is easy to incorporate into daily life, possibly offering a safer and more accessible option for managing abdominal obesity.
What evidence suggests that milk polar lipids might be an effective treatment for abdominal obesity?
Research has shown that certain fats in milk, known as polar lipids, might aid in obesity management by influencing fat metabolism. One study found that these fats, present in milk fat globule membranes, helped animals on high-fat diets gain less weight and reduce body fat. These lipids also appeared to lower blood levels of insulin and triglycerides, both linked to obesity and related health issues. Another study suggested that milk polar lipids can enhance gut health and reduce inflammation, both crucial for managing obesity. Evidence also indicates that these lipids can lower "bad" cholesterol (LDL) without affecting "good" cholesterol (HDL). These findings suggest that milk polar lipids could support weight management and improve overall health. In this trial, participants will receive either a milk polar lipid-rich dairy powder or a control dairy powder to evaluate these potential benefits.678910
Are You a Good Fit for This Trial?
This trial is for adults aged 40 to 70 with high LDL cholesterol (bad cholesterol) and a large waistline, indicating abdominal obesity. It's not suitable for individuals with gallbladder, thyroid, gut diseases, autoimmune or chronic inflammatory conditions, diabetes, recent antibiotic use, milk allergies/intolerances, or those on certain medications like statins.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume either a control dairy beverage or an MPL-rich dairy beverage daily
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dairy Powder
- Milk Polar Lipid-Rich Dairy Powder
Trial Overview
The study tests if consuming a dairy powder rich in milk polar lipids daily can improve heart health and reduce risk factors associated with heart disease in people with high cholesterol and abdominal obesity.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Daily consumption of 50 g of dairy powder containing 6.5 g MPL for 8 weeks.
Daily consumption of 50 g of dairy powder containing \<0.1 g MPL for 8 weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Connecticut
Lead Sponsor
Dairy Management Inc.
Industry Sponsor
Published Research Related to This Trial
Citations
Milk Fat Globule Membrane Attenuates High-Fat Diet ...
The aim of the current study was to investigate whether MFGM could prevent obesity through inhibiting adipogenesis and promoting brown remodeling of white ...
Milk Polar Lipids: Underappreciated Lipids with Emerging ...
Milk polar lipids suggest they may beneficially influence dysfunctional lipid metabolism, gut dysbiosis, inflammation, cardiovascular disease, gut health, and ...
Supplementation of polar lipids‐enriched milk fat globule ...
MFGM-PL treatment to HFD dams decreased the body weight gain and WAT mass as well as lowered the serum levels of insulin and triglycerides in male offspring at ...
Dietary milk phospholipids increase body fat and modulate ...
The study examined how dietary milk polar lipids affect gut permeability, systemic inflammation, and lipid metabolism during diet-induced obesity (DIO).
Milk Fat Globule Membrane Is Associated with Lower ...
Overall, MFGM phospholipid intake may significantly decrease the level of TC and LDL, while no significant changes in TG and HDL were observed.
Milk fat globule membrane proteins are crucial in ...
These results show that both MPL and MemP are indispensable in the construction of MFGM. Understanding their effects on digestion can provide new strategies.
Full article: Milk polar lipids composition and functionality
Safety evaluation of the consumption of high dose milk fat globule membrane in healthy adults: A double-blind, randomized controlled trial ...
Milk polar lipids reduce lipid cardiovascular risk factors in ...
Milk PL significantly reduced fasting and postprandial plasma concentrations of cholesterol and surrogate lipid markers of cardiovascular disease risk.
Supplementation of milk polar lipids to obese dams improves ...
Safety evaluation of the consumption of high dose milk fat globule membrane in healthy adults: a double-blind, randomized controlled trial ...
Safety and tolerance assessment of milk fat globule ...
MFGM-enriched formula was safe and well-tolerated in healthy term infants between 0 and 12 months, and total incidences of adverse events were similar to that ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.